AI startup Paige launched an AI-powered biomarker module that the company says can evaluate more than 505 genes and identify 1,228 molecular biomarkers from standard pathology slides.
At RSNA 2023, healthcare AI startup Paige announced a partnership with Nuance to launch what the companies say is “the largest digital consultation network in pathology." Paige’s digital pathology tools will be embedded into PowerShare, Nuance's nationwide image sharing network with the goal of connecting more pathology labs to expert second opinions.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Microsoft is making a strategic investment in Paige, which is leveraging AI for cancer diagnostics and treatment. Paige will also use Microsoft Azure as its cloud provider for the Paige Platform.
Check out new developments from Carrum Health, Equiva, imaware, Elo, Paige, Gozio Health and WELL Health.
When breast cancer spreads, it commonly invades the lymph nodes—structures that are part of the body's immune system. Paige's software is designed to find cancer in the lymph nodes that might otherwise be missed, like tiny collections of cancer cells called micrometastases.
Paige received clearance from the Food and Drug Administration for a clinical decision support tool to flag potential prostate cancer cases for pathologists to review.
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
Read about new developments from Stellar Health, Paige, venBio, and more.
Paige, a New York-based computational pathology startup, raised $100 million in a series C funding round. The company develops clinical decision support algorithms for oncology.
The company, whose technology won FDA Breakthrough Device designation earlier this year and which signed a deal with Philips earlier this month, plans to use the money to support FDA clearance and other efforts.